The Relationship Between Maxillary Growth and Speech in Children With a Unilateral Cleft Lip and Palate at 5 Years of Age.

5-Year-Old’ index CAPS-A maxillary growth speech outcome unilateral cleft lip and palate

Journal

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
ISSN: 1545-1569
Titre abrégé: Cleft Palate Craniofac J
Pays: United States
ID NLM: 9102566

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 24 4 2021
medline: 16 4 2022
entrez: 23 4 2021
Statut: ppublish

Résumé

This study sought to investigate the association between maxillary growth and speech outcomes for children with a repaired unilateral cleft lip and palate (UCLP) at 5 years of age. In all, 521 children (180 females and 341 males) with a nonsyndromic complete UCLP, born between 2007 and 2012 in England, Wales, and Northern Ireland were included in this study. Maxillary growth was analyzed using dental models scored by the 5-Year-Olds' index, and perceptual speech analyses were scored by the Cleft Audit Protocol for Speech - Augmented rating. Forty-one percent of the children achieved good maxillary growth (scores 1 and 2 on 5-Year-Old' index). Fifty percent of the children achieved normal speech (achieving UK speech standard 1). Maxillary growth was not found to have an impact on speech outcome when described by the 3 UK National Cleft Lip and Palate Speech Audit Outcome Standards. Analysis according to individual speech parameters showed dentalizations to be less prevalent in children with The findings from this study suggest that children with a history of complete UCLP, who have

Identifiants

pubmed: 33887986
doi: 10.1177/10556656211010620
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-461

Auteurs

Matthew Fell (M)

North Bristol NHS Trust, Bristol, United Kingdom.

Jibby Medina (J)

Clinical Effectiveness Unit, Royal College of Surgeons, London, United Kingdom.

Kate Fitzsimons (K)

Clinical Effectiveness Unit, Royal College of Surgeons, London, United Kingdom.

Miriam Seifert (M)

University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom.

Anne Roberts (A)

University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom.

Craig Russell (C)

Royal Hospital for Children, Glasgow, United Kingdom.

Scott Deacon (S)

University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH